Celgene is pleased to announce the 2015 Innovation Impact award winners: Cancer Support Community, Facing Our Risk of Cancer Empowered (FORCE) and the International Foundation for Autoimmune Arthritis. Now in its third year, the Celgene Innovation Impact award program is a natural outgrowth of the company’s commitment to innovation. The award program recognizes and honors patient and professional organizations that have shown excellence in crafting novel solutions that creatively meet patient, caregiver and/or healthcare providers’ needs in hematology, oncology and immune-inflammatory conditions.
This year’s theme, “Unleashing the Patient Voice in Research” focused on the inclusion of the patient voice at every step of the drug discovery and development continuum. Interactive web-based tools, patient registries, surveys, educational materials and even a “SHARE” button, were among the innovative projects and ideas submitted by the thirty-one organizations participating in this year’s program.
Winners were selected by a six-person volunteer judging panel
The 2015 winning applications are:
Cancer Support Community’s Patients 1st: A Model Program to Optimize the Patient Experience in a Cancer Clinical Trial is a new idea designed to prove that the integration of education, decision support and distress screening, referral and follow-up will improve the desirability of a clinical trial and reduce psychosocial barriers that could interrupt patient participation and overall satisfaction.
Facing Our Risk of Cancer Empowered’s IMplementing a Patient-centered Approach to Clinical Trials (IMPACT) will draw upon the organization’s ABOUT Patient-Powered Research Network and engage in a pilot program that seeks to improve clinical trial participation for hereditary breast and ovarian cancer by identifying patients’ information needs around clinical trials and developing patient-friendly education and clinical trial matching materials.
International Foundation for Autoimmune Arthritis’ Autoimmune Community Team (ACT): Redefining Researchis designed to gather a global pool of patients, industry and researchers to initiate discussions early in the drug discovery environment so that research ideas and dollars spent will better reflect the patient’s needs. The program enables patients who are usually unable to participate in research discussions, due to disease limitations and/or the inability to travel, to contribute through a flexible, virtual platform.
“We look forward to working with our patient and professional group partners to ensure that as science advances, Celgene’s efforts to develop new treatments for people living with cancer and immune-inflammatory disorders truly reflect the voice and the needs of the patients we serve,” shared VP, Patient Advocacy, Joel Beetsch, PhD.
To learn more about Celgene’s Innovation Impact award program, visit the website at www.innovationimpact.com